Pennsylvania

Launch of AbbVie’s Upadacitinib Expected to Cause a Stir in the US Rheumatoid Arthritis Market, According to Spherix Global Insights

EXTON, Pa., July 19, 2019 /PRNewswire/ -- The latest report included in Spherix's RealTime Dynamix™ Rheumatoid Arthritis (US) independent service comprises the responses of 101 US rheumatologists and captures the…
Continue Reading »